"Obesity is a chronic disease and, just like any other chronic disease, it should be treated as such," a spokesperson for Novo Nordisk said
Medicaid spending Medicaid programs cover some GLP-1 drugs to treat obesity in a dozen other states: California, Delaware, Kansas, Massachusetts, Michigan, Minnesota, Mississippi, New Hampshire, Pennsylvania, Rhode Island, Virginia and Wisconsin
P-rank scores show that SGLT-2 inhibitors were ranked first in reducing nonfatal MI (90.4%) (Additional file 1: Table S2)
The mechanisms may involve improved endothelial function, reduced inflammation, and effects on lipid metabolism beyond simple glucose control
In IBS rats, exendin-4 reduced stress-induced defecation and pain sensitivity through gut neurons [108]